Condition

HPV-Related Malignancy clinical trials and research

• 8Clinical trials
• 4Countries

Newest HPV-Related Malignancy clinical trials

All recruiting trials (8)

• Mail-delivered mouth rinse and saliva kits for HPV testing in people with HIV

  This project tests whether people living with HIV can collect mouth rinse and saliva samples at home, mail them in, and get HPV test results that match clinic-collected samples.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07087145

• Using SCG142 TCR-T cells to treat HPV-related cancers

  This study is testing a new type of immune cell treatment called SCG142 TCR-T cells to see if it can help people with advanced cancers related to HPV.

  Recruiting Phase 1 The Affiliated Hospital of Qingdao University · Qingdao, Shandong · NCT06544720

• Examining the Prognostic Value of Conization and HPV Status in Early Cervical Cancer

  This study is trying to see if having a negative high-risk HPV test after a certain surgery can help women with early-stage cervical cancer understand their chances of recovery and if it leads to better treatment outcomes.

  Recruiting Rambam Health Care Campus · Haifa · NCT06196190

• Combination treatment for recurrent or metastatic cervical cancer

  This study is testing if adding a new treatment called PRGN-2009 to pembrolizumab can help people with recurrent or metastatic cervical cancer who haven't responded to pembrolizumab alone.

  Recruiting at 3 sites Phase 2 Precigen, Inc · Little Rock, Arkansas and 2 other locations · NCT06157151

• Immunotherapy using E7 TCR-T cells for HPV-related cancers

  This study is testing a new immunotherapy using E7 TCR-T cells to see if it can help people with advanced HPV-related cancers like cervical and throat cancer feel better and improve their health.

  Recruiting at 3 sites Phase 2 Rutgers, The State University of New Jersey · Bethesda, Maryland and 2 other locations · NCT05686226

• E7 T-cell therapy for advanced HPV-related cancers

  This study is testing a new treatment using specially modified immune cells to see if it can help people with advanced cancers linked to HPV feel better and live longer.

  Recruiting at 2 sites Phase 1/2 Rutgers, The State University of New Jersey · New Brunswick, New Jersey and 1 other locations · NCT05639972

• Using blood tests to determine treatment timing for HPV-related throat cancer

  This study is testing if blood tests can help decide when to start treatment for people with HPV-related throat cancer after surgery, by checking their tumor DNA levels.

  Recruiting at 8 sites Phase 2 Memorial Sloan Kettering Cancer Center · Miami, Florida and 7 other locations · NCT05307939

• Investigating HPV and skin cancer risks in organ transplant recipients

  This study is trying to see if organ transplant recipients have a higher risk of HPV infections and skin cancer compared to people with normal immune systems.

  Recruiting at 3 sites Bispebjerg Hospital · Copenhagen NV, Capital Region and 2 other locations · NCT05284877

Related topics

Quick answers

How many HPV-Related Malignancy clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 4 countries. The most sites are in United States (5 trials), China (1 trial), Israel (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →